Date: 2015-12-17
Type of information: Series A financing round
Company: Poietis (France)
Investors: WiSEED (France) business angels BPIfrance (France) Conseil Régional d’Aquitaine (France) Banque Populaire Aquitaine Centre Atlantique (France) EADS Développement (France) Michelin Développement (France)
Amount: €2.5 million
Funding type: series A financing round, grant, loan
Planned used:
- Poietis will use the funds to industrialize Poietis Laser-Assisted Bioprinting technology and bring to market its first bioprinted tissues.
Others:
- • On December 17, 2015, Poietis, a french leader of bioprinting, announced the closing of a first round of financing of €2.5 million including a fundraising record of nearly €1 million via the crowdfunding platform WiSEED.
- The round A is conducted with WiSEED (leader and pioneer of equity crowdfunding, which is financing its 11th project in the health sector), Business Angels and historical shareholders. This capital increase of €1.2 million is complemented with grants, reimbursable advances and loans obtained from Bpifrance, the Conseil Régional d’Aquitaine, Banque Populaire Aquitaine Centre Atlantique, EADS Développement and Michelin Développement.
- This first round is on line with the quick start of the company leader in 3D printing of biological tissues. Indeed, a year after its inception and initial financing (€600k), Poietis has signed a first co-development partnership with BASF), signed the exclusive worldwide license for the laser-assisted bioprinting technology, and obtained the issuance of two patents in the US and Japan. Employing 19 people, Poietis plans to gradually increase its workforce to 25 people in 2017.
Therapeutic area: Technology - Services
Is general: Yes
